These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24981645)

  • 1. Drug delivery systems for overcoming the bioavailability of curcumin: not only the nanoparticle matters.
    Peng JR; Qian ZY
    Nanomedicine (Lond); 2014 May; 9(6):747-50. PubMed ID: 24981645
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo.
    Zhang J; Liang YC; Lin X; Zhu X; Yan L; Li S; Yang X; Zhu G; Rogach AL; Yu PK; Shi P; Tu LC; Chang CC; Zhang X; Chen X; Zhang W; Lee CS
    ACS Nano; 2015 Oct; 9(10):9741-56. PubMed ID: 26390118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon targeted curcumin microspheres laden with ascorbic acid for bioavailability enhancement.
    Karade PG; Jadhav NR
    J Microencapsul; 2018 Jun; 35(4):372-380. PubMed ID: 30010458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bioavailability of curcumin: problems and advancements.
    Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
    J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
    Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z
    Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoformulations of Nutraceuticals for Cancer Treatment.
    Illahi AF; Muhammad F; Akhtar B
    Crit Rev Eukaryot Gene Expr; 2019; 29(5):449-460. PubMed ID: 32422001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability.
    Shelma R; Sharma CP
    Carbohydr Polym; 2013 Jun; 95(1):441-8. PubMed ID: 23618291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological axis of curcumin-loaded vesicular drug delivery systems.
    Chellappan DK; Ng ZY; Wong JY; Hsu A; Wark P; Hansbro N; Taylor J; Panneerselvam J; Madheswaran T; Gupta G; Bebawy M; Hansbro PM; Dua K
    Future Med Chem; 2018 Apr; 10(8):839-844. PubMed ID: 29620416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin conjugated silica nanoparticles for improving bioavailability and its anticancer applications.
    Gangwar RK; Tomar GB; Dhumale VA; Zinjarde S; Sharma RB; Datar S
    J Agric Food Chem; 2013 Oct; 61(40):9632-7. PubMed ID: 24028689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
    Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
    J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conundrum and therapeutic potential of curcumin in drug delivery.
    Kumar A; Ahuja A; Ali J; Baboota S
    Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine serum albumin nanoparticles improve the antitumour activity of curcumin in a murine melanoma model.
    Camargo LEA; Brustolin Ludwig D; Tominaga TT; Carletto B; Favero GM; Mainardes RM; Khalil NM
    J Microencapsul; 2018 Aug; 35(5):467-474. PubMed ID: 30246573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual nanoparticle drug delivery: the future of anticancer therapies?
    King MR; Mohamed ZJ
    Nanomedicine (Lond); 2017 Jan; 12(2):95-98. PubMed ID: 27885896
    [No Abstract]   [Full Text] [Related]  

  • 15. Mucoadhesive Chitosan-Pectinate Nanoparticles for the Delivery of Curcumin to the Colon.
    Alkhader E; Billa N; Roberts CJ
    AAPS PharmSciTech; 2017 May; 18(4):1009-1018. PubMed ID: 27582072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.
    Kolter M; Wittmann M; Köll-Weber M; Süss R
    Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells.
    Raveendran R; Bhuvaneshwar G; Sharma CP
    J Biomater Appl; 2013 Mar; 27(7):811-27. PubMed ID: 22274881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can improving bioavailability improve the bioactivity of curcumin?
    Ji HF; Shen L
    Trends Pharmacol Sci; 2014 Jun; 35(6):265-6. PubMed ID: 24768507
    [No Abstract]   [Full Text] [Related]  

  • 19. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells.
    Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
    Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.